NCT01495715|WithdrawnPhase 3
Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
1 other identifier
SNT-III-011
Study Type
interventional
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredDec 2011
Brief Summary
The objective of the study is to determine whether administration of idebenone can shorten the time to improvement of visual acuity in patients with chronic vision loss due to LHON.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2011
Completed4 days until next milestone
First Posted
Study publicly available on registry
December 20, 2011
CompletedLast Updated
August 22, 2014
Status Verified
August 1, 2014
First QC Date
December 16, 2011
Last Update Submit
August 21, 2014
Conditions
Study Arms (2)
Idebenone
EXPERIMENTALDrug: Idebenone
Placebo
PLACEBO COMPARATORDrug: Placebo
Interventions
Eligibility Criteria
Age10 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
You may qualify if:
- Age \> or equal 10 years and \< 65 years
- Impaired visual acuity in affected eyes due to LHON: Visual acuity in best eye \>0.4 logMAR
- No explanation for visual loss besides LHON
You may not qualify if:
- Any previous use of idebenone
- Participation in another clinical trial of any investigational drug within 3 months prior to Baseline
- Previous participation in Study SNT-II-003 (RHODOS) for idebenone.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Optic Atrophy, Hereditary, Leber
Interventions
idebenone
Condition Hierarchy (Ancestors)
Optic Atrophies, HereditaryOptic AtrophyOptic Nerve DiseasesCranial Nerve DiseasesNervous System DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesEye Diseases, HereditaryEye DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMitochondrial DiseasesMetabolic DiseasesNutritional and Metabolic Diseases
0
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2011
First Posted
December 20, 2011
Last Updated
August 22, 2014
Record last verified: 2014-08